Barinthus Biotherapeutics (BRNS) EPS (Weighted Average and Diluted) (QoQ) (2020 - 2026)
Barinthus Biotherapeutics (BRNS) EPS (Weighted Average and Diluted) (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.15% |
| Dec 31, 2025 | 25.00% |
| Sep 30, 2025 | 30.77% |
| Jun 30, 2025 | -6.12% |
| Mar 31, 2025 | 3.92% |
| Dec 31, 2024 | -142.86% |
| Sep 30, 2024 | 51.16% |
| Jun 30, 2024 | -7.50% |
| Mar 31, 2024 | 11.11% |
| Dec 31, 2023 | -21.62% |
| Sep 30, 2023 | 40.32% |
| Jun 30, 2023 | -29.17% |
| Mar 31, 2023 | 12.73% |
| Dec 31, 2022 | -350.00% |
| Sep 30, 2022 | -46.34% |
| Jun 30, 2022 | 502.94% |
| Mar 31, 2022 | 117.89% |
| Dec 31, 2021 | -192.31% |
| Sep 30, 2021 | 79.69% |
| Jun 30, 2021 | 66.32% |